showed a trendp = 0.064
Although no differences were observed for overall survival ( Figure 2 A,B), patients with low levels of CD47 showed a trend of better progression-free survival ( p = 0.064) ( Figure 2 C) that reached the statistical significance after correcting for the presence of BAP1, GNAQ, and GNA11 mutations ( p = 0.0447) ( Figure 2 D).